PHILADELPHIA--(BUSINESS WIRE)--Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Danazol Capsules 50mg and 100mg. According to Wolters Kluwer, total sales of generic Danazol Capsules were $15 million in 2006. Danazol is a gonadotropin inhibitor, a sex hormone.
